Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02938403 · ClinicalTrials.gov registry record · NA
In Vivo Experience With NRT to Increase Adherence and Smoking Abstinence
A NA study, sponsored by University of Alabama at Birmingham.
- Completed
- Registry status
- NA
- Development phase
- 517
- Enrollment target
NCT02938403: Completed NA study, sponsored by University of Alabama at Birmingham.
NCT02938403 is a NA study that has completed, run by University of Alabama at Birmingham. The registered enrollment target is 517 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (63% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02938403, a NA study, has completed, sponsored by University of Alabama at Birmingham.
- COMPLETED
- Registry status
- NA
- Development phase
- 517 participants
- Enrollment target
Study Summary
This is a study to determine the efficacy of a smoking cessation intervention (nicotine replacement therapy (NRT) and counseling) done in a systematized manner with participants recruited from the UAB Substance Abuse Program. The definition of In Vivo experience is: use of the NRT medication during the session using specialized counseling focused around their experience of using NRT, including how the use of NRT may help them quit smoking, side effects, and smoking cessation expectancies. In this study those in the In Vivo group will put the patch on during Session 1 and given nicotine gum in Session 2 and will discuss the experience of wearing the patch or chewing the gum while they are in session. The control group will not put on the patch or chew gum during the sessions but will be given standard counseling regarding quitting smoking.
Primary Outcome
Smoking abstinence will be defined at 6 months as a CO\< or equal to 3ppm and no smoking over the last 7 days
Interventions
- BEHAVIORAL Standard Smoking Cessation Counseling
- BEHAVIORAL In vivo counseling
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 517 participants |
| Start Date | 2017-01 |
| Est. Completion | 2022-10-13 |
| Phase | NA |
What the finished NCT02938403 record still lists
NCT02938403 is an interventional study that assigns participants to a tested intervention. The registered 517 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (63% lower).
The record links to 0 conditions, and to 2 interventions - of which Standard Smoking Cessation Counseling is the first listed.
NCT02938403 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02938403 about?
NCT02938403 is a clinical study titled "In Vivo Experience With NRT to Increase Adherence and Smoking Abstinence". This is a study to determine the efficacy of a smoking cessation intervention (nicotine replacement therapy (NRT) and counseling) done in a systematized manner with participants recruited from the UAB Substance Abuse Program. The definition of In Vivo experience is: use of the NRT medication during ...
What is the current status of trial NCT02938403?
This trial is currently completed. It is a NA study. The enrollment target is 517 participants. The study started on 2017-01. Estimated completion is 2022-10-13.
What interventions are being tested in trial NCT02938403?
The interventions under investigation include: Standard Smoking Cessation Counseling (BEHAVIORAL), In vivo counseling (BEHAVIORAL).
Who is sponsoring clinical trial NCT02938403?
This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02938403's enrollment target sits among peer trials
517 191st of 2000 higher than 1,810 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05676450 · 517 participants · NA
Feasibility and Clinical Utility of Cell-free DNA (cfDNA) in Identifying Actionable Alterations and Minimal Residual Disease for Lymphoma Patients Across Community Centers in Texas
- NCT04524871 · 518 participants · Phase 1
A Study Evaluating the Efficacy and Safety of Multiple Immunotherapy-Based Treatment Combinations in Patients With Advanced Liver Cancers (Morpheus-Liver)
- NCT07112196 · 518 participants · Phase 2
Visugromab in Cachexia International Trial
- NCT05933083 · 516 participants · NA
MCNAIR Study: coMparative effeCtiveness of iN-person and teleheAlth cardIac Rehabilitation
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia